News

The patent protects claims related to the technology which has the ability to electronically process, display and distribute eligible prescription savings on the medications and therapies, which healthcare

The strategic collaboration leveraged Macrocyclic Template Chemistry, Tranzyme’s chemistry technology, in the discovery of active macrocycles against a range of biological targets. Resulting macrocycles feature high potency and

The acquisition is expected to strengthen cell-based screening and reagent platform at Evotec’s Hamburg site. CCS produces recombinant assay cell lines, assay-ready Frozen Instant Cells, qualified membranes, and

According to the study data, DepoVax-based vaccines offer rapid and long lasting immune response compared to the licensed anthrax vaccine BioThrax. Immunovaccine chief science officer Dr. Marc Mansour

Sinus Plumber is formulated using horseradish and hot peppers to relieve sinus, allergy and headache symptoms. GSC Products CEO and inventor of Sinus Buster Wayne Perry said the

Phase 3 Nexavar DECISION trial has demonstrated the improvement in progression-free survival in radioactive iodine refractory differentiated thyroid cancer patients. Bayer HealthCare global clinical development oncology vice president

The facility will be constructed by renovating an existing 18,000ft² light manufacturing plant on a 4.2 acre in Shelton, US. Id3A will design the overall facility as well

The trial that is being conducted at City of Hope Comprehensive Cancer Center, will assess the activity of CRLX101 in HER-2 negative gastric cancer patients with progressed disease

Under the purchase agreement, Maine will manufacture, market, sell and distribute laboratory products such as microbiological monitors in both 47mm and 56mm sizes, ready-to-use liquid growth media as